Sanderling has supported over 90 biomedical companies earning consistently high rates of return on its venture investments.
Investment Type: Venture Capital
Mentions in press and media 19
| Date | Title | Description | Category | Author | Source |
| 26.11.2016 | Chiesi Ven... | Glycomine, Inc. a biotechnolog... | - | - | citybizlis... |
| 10.10.2013 | No cathete... | The ViSi Mobile System, a wris... | - | - | medcitynew... |
| 05.09.2013 | BDC and FT... | Money seems to be flying aroun... | - | - | betakit.co... |
| 13.12.2011 | Sotera Wir... | Sotera Wireless, Inc., a San D... | funding U... | - | finsmes.co... |
| 18.08.2010 | Cancer dru... | Endocyte’s small-molecule drug... | - | - | medcitynew... |
| 04.08.2010 | Cancer dru... | It’s unclear when Gemin X will... | - | - | medcitynew... |
| 07.04.2010 | Torax Medi... | The device has not yet been cl... | - | - | medcitynew... |
| 07.04.2010 | Torax Medi... | By Brandon Glenn Torax Medica... | - | MedCity Ne... | massdevice... |
| 16.10.2009 | Cancer dru... | Promoted Covid-19’s terrible ... | - | - | medcitynew... |
| 16.04.2008 | Xytis gets... | Xytis, a privately-held biotec... | - | - | venturebea... |
Show more